Literature DB >> 1427384

Helicobacter pylori and peptic ulcer recurrence.

M Guslandi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1427384      PMCID： PMC1379506          DOI： 10.1136/gut.33.9.1293

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

Authors:  J P Miller; E B Faragher
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

Review 2.  The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.

Authors:  J P Miller; E B Faragher
Journal:  Scand J Gastroenterol Suppl       Date:  1989

3.  Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium.

Authors:  M Guslandi
Journal:  Acta Gastroenterol Belg       Date:  1983 Sep-Oct       Impact factor: 1.316

Review 4.  Implications of sucralfate-induced ulcer healing and relapse.

Authors:  S K Lam
Journal:  Am J Med       Date:  1989-06-09       Impact factor: 4.965

Review 5.  The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome.

Authors:  A J McLean; P M Harrison; L Ioannides-Demos; A J Byrne; P McCarthy; F J Dudley
Journal:  Aust N Z J Med       Date:  1985-06

6.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori.

Authors:  E A Rauws; G N Tytgat
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321
  6 in total
  1 in total

1.  Helicobacter pylori positive resistant duodenal ulcers.

Authors:  F I Tovey; L Baker; A P Jayaraj; Y C Yiu
Journal:  Gut       Date:  1993-11       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.